VPIM
XERS icon

Vanguard Personalized Indexing Management’s Xeris Biopharma Holdings XERS Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,561
Closed -$127K – 2084
2025
Q3 		$127K Buy
+15,561
New +$103K ﹤0.01% 1783

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Personalized Indexing Management's XERS Position: Q4 2025 in Review

Vanguard Personalized Indexing Management sold out of Xeris Biopharma Holdings (XERS) in Q4 2025, closing a stake of 15,561 shares — an estimated $127K sold.

Vanguard Personalized Indexing Management first reported a position in XERS in Q3 2025 and held it in 1 quarter. The position peaked at $127K in Q3 2025. 225 funds tracked by Wall St. Rank hold XERS as of Q4 2025.

  • Vanguard Personalized Indexing Management reported no remaining Xeris Biopharma Holdings position as of Q4 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 15,561 Xeris Biopharma Holdings shares in Q4 2025, an estimated $127K.
  • Vanguard Personalized Indexing Management first reported a position in Xeris Biopharma Holdings in Q3 2025 and held it in 1 quarter.
  • Vanguard Personalized Indexing Management's Xeris Biopharma Holdings position peaked at $127K in Q3 2025.
  • 225 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q4 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q4 2025, filed 13 Feb 2026.